Search

everythinglearnresearchcommunity

for

Search:↓

Correct diagnosis is crucial for treating overlapping conditions like NMOSD and SLE effectively.

Herbal treatments can help manage PCOS symptoms.

Abrocitinib at 100 mg and 200 mg daily may significantly improve moderate-to-severe atopic dermatitis in patients 12 years and older.

Ritlecitinib is safe and well-tolerated for treating alopecia areata in patients aged 12 and older.

Platelet-rich plasma may not be very effective for bone healing and hair growth due to a substance it contains that blocks these processes.

A gene mutation in mice causes hair loss, weak bones, and protein buildup, showing how protein processing issues can lead to diseases.

COVID-19 vaccines may rarely worsen hair loss in people with severe alopecia, but the benefits of vaccination still outweigh this risk.

Exemestane may protect bones by stimulating osteoblast growth through androgen-related pathways.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

A new surgical technique using vellus hair grafts effectively treated vitiligo without causing unwanted hair growth.

Oral dutasteride and topical pimecrolimus can safely and effectively treat Frontal Fibrosing Alopecia, leading to significant hair regrowth.

Both topical and oral finasteride are equally effective for treating male pattern baldness.

Tofacitinib helped some young children with severe hair loss grow their hair back without bad side effects.

Baricitinib is a promising treatment for alopecia areata in the UAE, but there are challenges with data and access.

Some treatments can help with a hair loss condition called alopecia areata, but none ensure lasting results; choices depend on the person, with JAK inhibitors showing promise for severe cases.

Steroid sulfatase inhibitors could help treat hormone-related disorders and cancers.

Topical JAK inhibitors may help children with alopecia areata regrow hair.

Oral tofacitinib shows promise in treating atopic dermatitis and alopecia areata, but only slight improvement in vitiligo.

Tofacitinib helped regrow hair in patients with alopecia, with few side effects.

Some alternative vitiligo treatments show promise, but none are as effective as psoralens and UVA.

Topical tofacitinib may effectively and safely regrow facial hair in some people with alopecia areata.

Oral dutasteride works better for hair loss, but has more sexual side effects; intralesional dutasteride is a possible alternative.

Previous alopecia areata treatments do not affect the long-term effectiveness of ritlecitinib.

JAK inhibitors do not increase cancer risk in severe alopecia areata compared to traditional treatments.

JAK-inhibitors for alopecia areata are generally safe with mostly mild side effects and a low rate of treatment withdrawal.

Raltegravir may cause hair loss in some patients.

JAK inhibitors effectively regrow hair in alopecia areata but hair loss often returns after stopping treatment.

JAK inhibitors show promise for treating alopecia areata but have serious side effects.

Tofacitinib helped improve symptoms and hair growth in a patient with Aicardi-Goutières syndrome.

JAK inhibitors like tofacitinib can effectively treat severe alopecia areata.